In both subgroups, patients with higher CALU exhibited universally worse survival than those with relatively lower CALU ( Figure 5b, c, e and f ), except for TCGA GBM, which also showed an apparent trend.
← all excerpts
Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma.
1
—
—